The prognosis for multiple myeloma varies based on several factors:

- Five-Year Survival Rate: The five-year relative survival rate in the United States is 59.8%. This means about 60 out of 100 people will be alive five years after diagnosis
- Stage of Diagnosis: Early-stage myeloma has better survival rates. For Show Full Answer

The prognosis for multiple myeloma varies based on several factors:

- Five-Year Survival Rate: The five-year relative survival rate in the United States is 59.8%. This means about 60 out of 100 people will be alive five years after diagnosis.
- Stage of Diagnosis: Early-stage myeloma has better survival rates. For localized myeloma, around 79.5% live at least five years.
- Stage-Specific Prognosis:
- Stage 1: Approximately 5 years
- Stage 2: Approximately 3.5 years
- Stage 3: Approximately 2.5 years

Survival rates have improved due to new treatments, and some people can live up to or beyond 20 years.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Multiple Myeloma Prognosis: Survival Rates, Light Chain, and More Factors | MyMyelomaTeam

Stage 2 Multiple Myeloma Prognosis: Fear, Hope, and Understanding Survival Rates | MyMyelomaTeam